A team of world-renowned scientists from Newcastle are hoping to reverse the ageing process by developing a range of supplements and skincare products.

Molecular biologist Dr Nichola Conlon founded Nuchido to develop products designed to stimulate the body’s own self-repair systems.

The company, which is based at Dissington Hall, is currently carrying out clinical testing on how ageing can be reversed and plans to release its range of products in spring 2019.

Dr Conlon, who gained her PhD from Newcastle University, said: “There have been four astonishing scientific breakthroughs in the area of ageing research in recent years and it is these breakthroughs – each of which demonstrated real rejuvenation - that are forming the basis of Nuchido supplements and skincare.

“Translating these effects into products which will be readily available means it will be entirely possible for people to regain their youthful appearance and rejuvenate themselves both internally and externally without having to resort to the surgeon’s knife.

“As science has discovered more and more about how and why we age, we have been able to use that information to create products that give unprecedented results.”

Dr Conlon has travelled the world speaking at conferences about the impact science can have on the ageing process. She has spoken at the Master Investor event for the longevity industry in London, as well as Thinking Digital in Newcastle.

“The first thing we are launching is a supplement,” said Dr Conlon. “In the last two years there has been a real change in the sceince around ageing and scientists really understand the biology of how we age. We want to put that into products that people can use now.”

Nuchido’s trials centre on the use of NAD+, a molecule found in cells that regulates ageing, but which decreases over time. NAD+ has been tested on animals such as mice and worms, and was found to protect the body from inflammation, DNA damage, and failing mitochondria.

In one of Nuchido’s clinical trials, the company evaluated the effects of one of its products that boosts the NAD+ levels of older people. It found that NAD+ could be boosted back to levels associated with people approximately 15 years younger, improving their energy levels.

Nuchido will soon carry out more accurate double blind trials involving placebo supplements. These trials are designed to more accurately gauge whether the products are improving the health of the users.

The products are set to go on sale on Nuchido’s website this spring. The company is planning on selling to UK consumers as well as in the US, where the effects of NAD+ are more well known.